Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2026-03-18 @ 12:00 AM
Study NCT ID:
NCT04377932
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-17
First Post:
2020-05-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Sponsor:
Baylor College of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2040-08-26
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-04
First Submit QC Date:
None
Study First Post Date:
2020-05-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-11-17
Last Update Post Date Type:
ESTIMATED